Replies to post #3579 on Repros Therapeutics Inc (RPRX)

[quantumdot]

Bob, perhaps you are right, although if the FDA want a larger safety database for chronic use at the 50mg dose then the short duration of Tx in the anemia trial is unlikely to provide data that they will consider meaningful.